Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women
NCT03432468
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
102
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Valsartan 1
DRUG:
Valsartan 80 mg
Sponsor
LanZhou University